Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 22,967 shares at $31.87 ($732K) on 2022-04-18, disclosed to the SEC on 2022-04-19.
Open-market sale of $732k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.87 | 11,467 | $365K | 49.9% |
| 2 | $31.87 | 11,467 | $365K | 49.9% |
| 3 | $32.64 | 33 | $1K | 0.1% |
| Total | $31.87 avg | 22,967 | $732K | 100% |
| Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |
| ITOS | SELL | 2022-01-26 | $1.0M | — | Filing → |